All Articles

QuadReal's appointment of Deloitte veteran Trevor Nakka signals a strategic pivot, adding elite financial governance to its $98.5B portfolio to fuel a disciplined global expansion.

The Dallas Cowboys are using a new device to build muscle. It’s part of a high-stakes trend where technology is redefining athlete recovery and longevity.

A novel probiotic, sourced from an elite athlete's gut, has navigated the FDA's complex regulatory maze, signaling a major shift for the entire industry.

With an $18M Series A, Novellia is flipping the script on real-world data, empowering patients to solve a decades-old, multi-billion-dollar R&D bottleneck.

Shake Shack's lowered guidance reveals a consumer trading down from premium burgers, a worrying sign for the entire fast-casual industry's health.

AI is moving from the cloud to the world around us. New, powerful hardware is making our cities and industries smarter, but it demands a new level of trust.

As Motorcar Parts of America preps its FY2026 report, investors await answers on declining revenue and the strategic review of its once-touted EV business.

Browser innovator Shift renews its $25K Impact Grant, fueling sustainable startups as the tech industry grapples with its growing environmental footprint.

Inipharm's INI-822 study leverages genetic insights for an oral MASH therapy, challenging injectable rivals and offering new hope for high-risk patients.

A new grant program for police tech seems simple, but Veritone's partnership with Police1 is a shrewd move to overcome the biggest sales hurdle: budget.

As Recursion heads to a key investor conference, it must prove its AI-powered drug discovery platform can deliver financial results, not just scientific promise.

A Canadian firm is betting big on natural hydrogen, a clean energy source found underground. With new funding and political clout, is this the future?

Zacks Investment Management launches two new income ETFs, ZINC and PRIZ, targeting an 8% yield. But can their 'simple', research-driven approach deliver?

With a $1.25 billion investment from Apollo Funds, McKesson is spinning off its medical supply unit. Is this a cure for corporate bloat or a new symptom of financialization in healthcare?

Frazier Healthcare Partners adds Milton Boyer as an EIR, signaling a strategic push into the complex pharmaceutical manufacturing sector with a proven operator.

As AI-powered cyberattacks escalate, one company is fighting fire with fire. Skyhawk Security's award-winning AI Red Team is a game-changer.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

Upcoming study results for Bayer's KERENDIA could unlock a new treatment for millions with non-diabetic chronic kidney disease, a vast and underserved group.

A new partnership is democratizing science for wellness brands, making it faster and cheaper to prove their final products work and earn customer trust.

Penn Highlands Healthcare is offering up to $65K in loan repayment to build its workforce. Is this the new blueprint for solving talent shortages?